ANAPTYSBIO, INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ANAPTYSBIO, INC has filed 716 SEC EDGAR filings since 06 Jul 2006

SEC filing history

Showing 626-650 of 709 matching filings.

Per page
25
Current page
26
8-K File 001-37985

8-K

Filing date
10 Aug 2017
Reporting date
10 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Aug 2017
Reporting date
04 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Aug 2017
Reporting date
01 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2017
Reporting date
26 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37985

8-K

Filing date
27 Jul 2017
Reporting date
21 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37985

FORM 8-K

Filing date
12 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89797

SC 13G

Filing date
13 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-37985

10-K

Filing date
08 Mar 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37985

8-K

Filing date
08 Mar 2017
Reporting date
08 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37985

FORM 8-K

Filing date
02 Mar 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-89797

FRAZIER HEALTHCARE V, L.P. / ANAPTYSBIO, INC. -- SCHEDULE 13D

Filing date
10 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89797

SC 13G filing

Filing date
08 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Feb 2017
Reporting date
02 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .